Stenocare Feed

2026-09-07 16:05:46 STENOCARE: Germany's DKK 8.5 billion medical cannabis market in continued uncertainty over the new reimbursement rules

2026-08-20 08:00:00 STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter 0,95 DKK | -6,86% | 0,30 MDKK

2026-08-07 08:00:00 STENOCARE: France reaches important milestone towards permanent legalisation of medical cannabis 0,93 DKK | -1,69% | 0,21 MDKK

2026-07-03 19:37:11 STENOCARE completes integration of CannGros ApS

2026-05-07 08:00:00 STENOCARE: Interim report first quarter 2026 1,28 DKK | -13,18% | 0,59 MDKK

2026-04-29 15:21:34 STENOCARE: Communiqué from Annual General Meeting 1,05 DKK | -2,76% | 0,05 MDKK

2026-04-07 17:45:00 Notice to Annual General Meeting in STENOCARE A/S 1,03 DKK | +0,98% | 0,19 MDKK

2026-03-26 08:17:14 STENOCARE A/S publishes Annual Report 2025 1,21 DKK | +50,25% | 1,81 MDKK

2026-02-26 08:00:00 STENOCARE: Interim report fourth quarter and Financial Statement Release 2025 1,42 DKK | +3,27% | 0,27 MDKK

2026-02-11 08:00:00 STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership 1,54 DKK | +6,94% | 0,51 MDKK

2026-01-27 16:27:10 STENOCARE: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany 1,46 DKK | -1,02% | 0,57 MDKK

2025-12-30 11:19:05 Trading in STENOCARE shares by closely related party to board member 1,48 DKK | -3,58% | 0,41 MDKK

2025-11-19 19:56:57 STENOCARE share analyst's comments on the CannGros acquisition 1,85 DKK | -2,12% | 2,81 MDKK

2025-11-18 09:59:38 STENOCARE: Correction of total shares issued and total nominal share capital: 2,08 DKK | -23,53% | 3,39 MDKK

2025-11-17 17:56:40 STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal 2,08 DKK | -23,53% | 3,39 MDKK

2025-11-17 17:01:00 STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal 2,08 DKK | -23,53% | 3,39 MDKK

2025-10-22 08:00:00 STENOCARE: Interim report third quarter 2025 1,32 DKK | -0,75% | 0,17 MDKK

2025-08-27 21:30:59 Trading in STENOCARE shares by closely related party to board member 1,24 DKK | -9,19% | 1,97 MDKK

2025-08-21 08:00:00 STENOCARE: Interim report second quarter 2025 0,78 DKK | +9,86% | 0,37 MDKK

2025-05-15 11:36:09 Communiqué from the Annual General Meeting of STENOCARE 0,36 DKK | -5,74% | 0,06 MDKK

2025-05-08 08:00:00 STENOCARE: Interim report first quarter 2025 0,38 DKK | +4,09% | 0,05 MDKK

2025-05-02 14:35:58 Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE 0,39 DKK | -2,52% | 0,08 MDKK

2025-04-22 15:01:47 Notice to Annual General Meeting in STENOCARE A/S 0,33 DKK | -0,30% | 0,02 MDKK

2025-04-03 08:00:00 STENOCARE ASTRUM 10-10 Oil Product Approved for Reimbursement in Germany 0,36 DKK | -5,00% | 0,06 MDKK

2025-03-31 08:00:00 STENOCARE Begins Sales of New CBD100 Oil Product in Denmark 0,37 DKK | +8,88% | 0,09 MDKK

2025-03-28 13:25:32 STENOCARE interview with Proinvestor.com - Annual Report 2024 0,34 DKK | -10,11% | 0,09 MDKK

2025-03-27 08:01:46 STENOCARE A/S publishes Annual Report 2024 0,38 DKK | +1,62% | 0,02 MDKK

2025-02-27 09:04:04 STENOCARE: Q4 and Annual Financial Statement Release 2024 0,43 DKK | -3,59% | 0,13 MDKK

2025-02-14 08:56:53 STENOCARE - The innovative ASTRUM 10-10 product is now available for Australian patients 0,50 DKK | +16,98% | 0,50 MDKK

2025-01-29 10:52:54 STENOCARE A/S Embarks on Strategic Transformation with HQ Relocation and Cultivation Facility Exit 0,57 DKK | +5,56% | 0,20 MDKK

2025-01-22 12:37:35 STENOCARE A/S: Conditional Rights Issue subscribed to 45.0 percent 0,89 DKK | -1,66% | 0,04 MDKK

2025-01-20 12:29:14 STENOCARE - Final deadline for Subscription to New Shares at DKK 0.50 Each 0,84 DKK | +5,62% | 0,05 MDKK

2025-01-17 08:00:00 STENOCARE - Final deadline Soon for Subscription to New Shares at DKK 0.50 Each 0,80 DKK | -3,03% | 0,02 MDKK

2025-01-15 11:57:05 STENOCARE - The new innovative ASTRUM 10-10 product is now available for German patients 0,80 DKK | +13,48% | 0,16 MDKK

2025-01-15 08:00:00 STENOCARE - Deadline Soon for Subscription to New Shares at DKK 0.50 Each 0,80 DKK | +13,48% | 0,16 MDKK

2025-01-15 08:00:00 STENOCARE - Deadline for tegning af nye aktier til 0,50 kr. pr. stk. nærmer sig 0,80 DKK | +13,48% | 0,16 MDKK

2025-01-10 17:03:44 STENOCARE A/S announces guarantee commitments in ongoing rights issue

2025-01-09 20:02:45 STENOCARE - Deadline for tegning af nye aktier til 0,50 kr. pr. stk. nærmer sig 0,83 DKK | -10,70% | 0,15 MDKK

2025-01-09 19:55:43 STENOCARE - Deadline soon to subscribe for new shares at DKK 0.50 each 0,83 DKK | -10,70% | 0,15 MDKK

2025-01-07 11:22:29 STENOCARE A/S: The subscription period in Stenocare's conditional rights issue begins today for the time limited offer of DKK 0,50 per new share 0,97 DKK | -7,14% | 0,22 MDKK

2025-01-03 11:21:03 STENOCARE's Innovative ASTRUM 10-10 Product Now Available for Norwegian Patients 1,21 DKK | +46,37% | 0,39 MDKK

2024-12-18 19:00:27 STENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK 0,78 DKK | -9,68% | 0,23 MDKK

2024-12-18 13:37:59 Communiqué from extraordinary general meeting in STENOCARE 0,87 DKK | +3,33% | 0,06 MDKK

2024-12-17 08:00:00 STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil 0,84 DKK | -3,85% | 0,14 MDKK

2024-12-10 15:38:44 STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com 0,87 DKK | +4,00% | 0,07 MDKK

2024-12-02 08:00:00 STENOCARE - Innovative New ASTRUM Product Officially Approved for Sale in Norway 1,06 DKK | -7,35% | 0,15 MDKK

2024-11-28 22:14:53 STENOCARE Celebrates Denmark's Permanent Legalisation of Medical Cannabis 1,14 DKK | +7,37% | 0,67 MDKK

2024-11-26 17:46:33 STENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production 0,96 DKK | -13,64% | 0,30 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode